NEW YORK — The US Food and Drug Administration this week granted separate Emergency Use Authorizations for SARS-CoV-2 tests developed by Seasun Biomaterials and Zeus Scientific.
Seasun's AQ-TOP COVID-19 Rapid Detection Kit Plus is a real-time reverse transcription loop mediated isothermal amplification test designed to detect the SARS-CoV-2 ORF1ab and N genes in upper respiratory and bronchoalveolar lavage specimens.